Return To Phacilitate
  • When 7-9 September, 2026
  • Where InterContinental Barcelona
  • Search
Sponsorship Opportunities Apply to attend
SEARCH

About us

We are driven by a single mission: to transform patient outcomes by building the connections that power life-changing treatments.

At Phacilitate, we don't just bring people together — we create exceptional, high-impact experiences through year-round knowledge sharing, events, and thriving micro-communities.

We believe true innovation happens when collaboration takes centre stage. The whole is greater than the sum of its parts, and by fostering powerful partnerships and open knowledge exchange, we help accelerate therapies from breakthrough to patient, where they matter most.
 

Why Europe? Who Attends ATE?

Advanced Therapies Europe in numbers

7–9 September 2026 | InterContinental Hotel, Barcelona 

600
Attendees
30
Countries represented
1000
1-2-1 meetings
30
Hours of content, networking & partnering

Why Europe? Why now?

Europe is at a defining moment in advanced therapies.

The science is proven. The pipeline is maturing. But commercial success remains the hardest part.

Fragmented regulation, inconsistent market access, and reimbursement complexity are holding the continent back. Not for lack of innovation, but lack of alignment.

Advanced Therapies Europe exists to change that.

Three days. The leaders, investors, and innovators who are actually moving the needle. Targeted content, curated networking, and high-value connections. Built specifically for the European CGT landscape.
 

Apply to attend

Why Attend?

This isn’t a traditional conference — it’s an experience designed to foster genuine collaboration and strategic growth. Expect smart conversations, curated meetings, and the kind of networking that leads to real results.

Built for Europe's advanced therapies market

A curated room, not a crowded one

Content that gets people talking, not just listening

Advancing Europe's path to commercial competitiveness

A gateway to CGT investment in Europe

Download the Delegate Pack

Everything you need to know about Advanced Therapies Europe 2026 in one place.

Inside the delegate pack:

  • A breakdown of attending investors, pharma, and biotech companies
  • Insight into the types of deals, partnerships, and conversations happening
  • How the 1:1 meeting concierge works and how you’re matched
  • An overview of the agenda, themes, and key discussion area
     

Download the Delegate Pack

2026 Speakers

Search
We're sorry, but we couldn't find any results that match your search criteria. Please try again with different keywords or filters.
Loading
Loading
  • All
  • 0 - 9
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z
  • Letter
    • P

Who Attends?

Advanced Therapies Europe brings together a carefully balanced mix of senior leaders from across the CGT ecosystem.

From therapeutic developers and investors to CDMOs, regulators and solution providers, every attendee is here for a reason.

600 attendees. 36 countries. One room.

A circular ecosystem diagram showing the range of attendees at Advanced Therapies Europe 2026, including therapeutic developers, investors, CDMOs, academics, regulators, patient advocacy groups, and tools and technology providers.

See Who Joined us in 2025

  • Thanks so much for an amazing networking opportunity. I had some great meetings with potential partners.
    Lynn Ficher
    Kmak Capital
  • If you want to know what’s happening in Advanced Therapies within Europe, this is the place.
    Chus Castillo
    IGES Spain Pharma Consulting
  • Very good spread of topics, knowledgeable speakers, informative exhibitions and great for networking!
    Magda Papadaki
    MSD

CPD Accredited

Advanced Therapies Europe is officially accredited by The CPD Group, the UK’s largest and most trusted continuing professional development accreditation body. This recognition reflects the exceptional educational value of our agenda, speakers, and scientific content.

By attending ATE, you’ll not only gain access to high-level insights from across the advanced therapies landscape — you'll also be able to:

  • Earn CPD credits recognised by employers & professional bodies
  • Receive a certificate of attendance at no additional cost
  • Demonstrate your ongoing commitment to industry excellence

Whether you're attending to stay ahead of regulatory changes, deepen your scientific understanding, or expand your commercial skillset, your time at ATE counts toward your professional growth.

 

Find out more

CPD Accrediation

FAQ

Advanced Therapies Europe is a focused conference and networking event for the advanced therapies and regenerative medicine community. It brings together key people across European biotech and life sciences to discuss innovation, investment and bringing new treatments to market.

The event will take place on 7-9 September 2026 at InterContinental Barcelona, Spain.

If you work in cell and gene therapy, regenerative medicine, biotech investment or manufacturing, this event is designed for you. It is ideal for senior leaders, scientists, investors, regulators and solution providers involved in the future of advanced therapies in Europe.

Yes! Advanced Therapies Europe is an intimate event designed for early-stage biotechs and startups looking to breakthrough to the next stage of development. In 2025, we had a record $1bn+ active investment fund in the room, with nearly 1000 curated meetings taking place via our networking app. The format prioritises quality over scale, so you spend less time searching and more time progressing deals, partnerships and funding conversations.

Unlike larger exhibitions, this event focuses on in-depth discussion, targeted networking and knowledge sharing. It is smaller and more selective, with around 600 senior attendees, designed to encourage meaningful conversations and connections.

Sessions explore a wide range of issues across the advanced therapies field, including clinical development, commercial strategy, regulatory planning, manufacturing, market access and patient involvement.

Yes. The event includes a one-to-one partnering system so you can arrange meetings with potential collaborators, investors or clients before and during the event.

Yes. The event is built to help you meet deal makers, funders and biotech leaders from across the sector. It is a valuable chance to connect with people who influence the direction of advanced therapies in Europe.


 

Search